Published in the Orphanet Journal of Rare Diseases, this paper reveals how Mastermind determined the genetic prevalence of ENPP1 deficiency to be 3X the previous estimate.
We help provide insights into key genetic drivers of diseases and relevant biomarkers. By working together to understand this data, we enable scientists and researchers to make more informed decisions on programs of interest. To learn more about how we can partner together to find your genomic variant solutions, we invite you to click on the link below.